nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—systemic scleroderma	0.797	1	CpDpCtD
Naratriptan—Myalgia—Lisinopril—systemic scleroderma	0.000192	0.000947	CcSEcCtD
Naratriptan—Anxiety—Lisinopril—systemic scleroderma	0.000191	0.000944	CcSEcCtD
Naratriptan—Dyspnoea—Leflunomide—systemic scleroderma	0.000191	0.000942	CcSEcCtD
Naratriptan—Hypotension—Mycophenolic acid—systemic scleroderma	0.000191	0.000942	CcSEcCtD
Naratriptan—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000937	CcSEcCtD
Naratriptan—Discomfort—Lisinopril—systemic scleroderma	0.00019	0.000936	CcSEcCtD
Naratriptan—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00019	0.000935	CcSEcCtD
Naratriptan—Vomiting—Mometasone—systemic scleroderma	0.000188	0.000928	CcSEcCtD
Naratriptan—Dry mouth—Lisinopril—systemic scleroderma	0.000188	0.000926	CcSEcCtD
Naratriptan—Feeling abnormal—Azathioprine—systemic scleroderma	0.000187	0.000922	CcSEcCtD
Naratriptan—Rash—Mometasone—systemic scleroderma	0.000187	0.00092	CcSEcCtD
Naratriptan—Asthenia—Captopril—systemic scleroderma	0.000186	0.00092	CcSEcCtD
Naratriptan—Dermatitis—Mometasone—systemic scleroderma	0.000186	0.000919	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000186	0.000918	CcSEcCtD
Naratriptan—Confusional state—Lisinopril—systemic scleroderma	0.000186	0.000915	CcSEcCtD
Naratriptan—Headache—Mometasone—systemic scleroderma	0.000185	0.000914	CcSEcCtD
Naratriptan—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000913	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000185	0.000912	CcSEcCtD
Naratriptan—Fatigue—Leflunomide—systemic scleroderma	0.000185	0.000911	CcSEcCtD
Naratriptan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000184	0.000908	CcSEcCtD
Naratriptan—Oedema—Lisinopril—systemic scleroderma	0.000184	0.000908	CcSEcCtD
Naratriptan—Pruritus—Captopril—systemic scleroderma	0.000184	0.000907	CcSEcCtD
Naratriptan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000184	0.000905	CcSEcCtD
Naratriptan—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000904	CcSEcCtD
Naratriptan—Pain—Leflunomide—systemic scleroderma	0.000183	0.000903	CcSEcCtD
Naratriptan—Constipation—Leflunomide—systemic scleroderma	0.000183	0.000903	CcSEcCtD
Naratriptan—Infection—Lisinopril—systemic scleroderma	0.000183	0.000902	CcSEcCtD
Naratriptan—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000901	CcSEcCtD
Naratriptan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000182	0.000898	CcSEcCtD
Naratriptan—Somnolence—Mycophenolic acid—systemic scleroderma	0.000182	0.000896	CcSEcCtD
Naratriptan—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000896	CcSEcCtD
Naratriptan—Shock—Lisinopril—systemic scleroderma	0.000181	0.000893	CcSEcCtD
Naratriptan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00018	0.000889	CcSEcCtD
Naratriptan—Body temperature increased—Azathioprine—systemic scleroderma	0.000179	0.000884	CcSEcCtD
Naratriptan—Skin disorder—Lisinopril—systemic scleroderma	0.000179	0.000882	CcSEcCtD
Naratriptan—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000879	CcSEcCtD
Naratriptan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000178	0.000877	CcSEcCtD
Naratriptan—Diarrhoea—Captopril—systemic scleroderma	0.000178	0.000877	CcSEcCtD
Naratriptan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000876	CcSEcCtD
Naratriptan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000874	CcSEcCtD
Naratriptan—Feeling abnormal—Leflunomide—systemic scleroderma	0.000177	0.000871	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000176	0.00087	CcSEcCtD
Naratriptan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000176	0.000869	CcSEcCtD
Naratriptan—Nausea—Mometasone—systemic scleroderma	0.000176	0.000867	CcSEcCtD
Naratriptan—Constipation—Mycophenolic acid—systemic scleroderma	0.000175	0.000862	CcSEcCtD
Naratriptan—Pain—Mycophenolic acid—systemic scleroderma	0.000175	0.000862	CcSEcCtD
Naratriptan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000861	CcSEcCtD
Naratriptan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000856	CcSEcCtD
Naratriptan—Hyperglycaemia—Prednisone—systemic scleroderma	0.000173	0.000855	CcSEcCtD
Naratriptan—Cough—Mycophenolate mofetil—systemic scleroderma	0.000172	0.00085	CcSEcCtD
Naratriptan—Hypotension—Lisinopril—systemic scleroderma	0.000172	0.000848	CcSEcCtD
Naratriptan—Dizziness—Captopril—systemic scleroderma	0.000172	0.000848	CcSEcCtD
Naratriptan—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000172	0.000846	CcSEcCtD
Naratriptan—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000844	CcSEcCtD
Naratriptan—Depression—Prednisone—systemic scleroderma	0.000171	0.000843	CcSEcCtD
Naratriptan—Urticaria—Leflunomide—systemic scleroderma	0.00017	0.000839	CcSEcCtD
Naratriptan—Body temperature increased—Leflunomide—systemic scleroderma	0.000169	0.000835	CcSEcCtD
Naratriptan—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000169	0.000833	CcSEcCtD
Naratriptan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000168	0.00083	CcSEcCtD
Naratriptan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000168	0.00083	CcSEcCtD
Naratriptan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000168	0.00083	CcSEcCtD
Naratriptan—Myocardial infarction—Prednisone—systemic scleroderma	0.000168	0.000829	CcSEcCtD
Naratriptan—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000168	0.000829	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000168	0.000827	CcSEcCtD
Naratriptan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000827	CcSEcCtD
Naratriptan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000167	0.000824	CcSEcCtD
Naratriptan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00082	CcSEcCtD
Naratriptan—Paraesthesia—Lisinopril—systemic scleroderma	0.000165	0.000815	CcSEcCtD
Naratriptan—Vomiting—Captopril—systemic scleroderma	0.000165	0.000815	CcSEcCtD
Naratriptan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000811	CcSEcCtD
Naratriptan—Dyspnoea—Lisinopril—systemic scleroderma	0.000164	0.000809	CcSEcCtD
Naratriptan—Rash—Captopril—systemic scleroderma	0.000164	0.000808	CcSEcCtD
Naratriptan—Dermatitis—Captopril—systemic scleroderma	0.000164	0.000807	CcSEcCtD
Naratriptan—Somnolence—Lisinopril—systemic scleroderma	0.000164	0.000807	CcSEcCtD
Naratriptan—Headache—Captopril—systemic scleroderma	0.000163	0.000803	CcSEcCtD
Naratriptan—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000802	CcSEcCtD
Naratriptan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000162	0.000797	CcSEcCtD
Naratriptan—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000795	CcSEcCtD
Naratriptan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000795	CcSEcCtD
Naratriptan—Asthma—Methotrexate—systemic scleroderma	0.000161	0.000792	CcSEcCtD
Naratriptan—Infection—Mycophenolate mofetil—systemic scleroderma	0.00016	0.00079	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000159	0.000784	CcSEcCtD
Naratriptan—Fatigue—Lisinopril—systemic scleroderma	0.000159	0.000783	CcSEcCtD
Naratriptan—Shock—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000782	CcSEcCtD
Naratriptan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00078	CcSEcCtD
Naratriptan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000779	CcSEcCtD
Naratriptan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000158	0.000778	CcSEcCtD
Naratriptan—Pain—Lisinopril—systemic scleroderma	0.000157	0.000776	CcSEcCtD
Naratriptan—Constipation—Lisinopril—systemic scleroderma	0.000157	0.000776	CcSEcCtD
Naratriptan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000772	CcSEcCtD
Naratriptan—Bradycardia—Prednisone—systemic scleroderma	0.000157	0.000772	CcSEcCtD
Naratriptan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000769	CcSEcCtD
Naratriptan—Diarrhoea—Azathioprine—systemic scleroderma	0.000155	0.000765	CcSEcCtD
Naratriptan—Haemoglobin—Prednisone—systemic scleroderma	0.000155	0.000763	CcSEcCtD
Naratriptan—Nausea—Captopril—systemic scleroderma	0.000154	0.000761	CcSEcCtD
Naratriptan—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000154	0.00076	CcSEcCtD
Naratriptan—Haemorrhage—Prednisone—systemic scleroderma	0.000154	0.000759	CcSEcCtD
Naratriptan—Asthenia—Leflunomide—systemic scleroderma	0.000154	0.000758	CcSEcCtD
Naratriptan—Hallucination—Prednisone—systemic scleroderma	0.000153	0.000755	CcSEcCtD
Naratriptan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000152	0.000748	CcSEcCtD
Naratriptan—Pruritus—Leflunomide—systemic scleroderma	0.000152	0.000747	CcSEcCtD
Naratriptan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000743	CcSEcCtD
Naratriptan—Dizziness—Azathioprine—systemic scleroderma	0.00015	0.00074	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000725	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000147	0.000723	CcSEcCtD
Naratriptan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000147	0.000723	CcSEcCtD
Naratriptan—Diarrhoea—Leflunomide—systemic scleroderma	0.000147	0.000723	CcSEcCtD
Naratriptan—Urticaria—Lisinopril—systemic scleroderma	0.000146	0.000721	CcSEcCtD
Naratriptan—Body temperature increased—Lisinopril—systemic scleroderma	0.000146	0.000718	CcSEcCtD
Naratriptan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000714	CcSEcCtD
Naratriptan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000145	0.000713	CcSEcCtD
Naratriptan—Vomiting—Azathioprine—systemic scleroderma	0.000144	0.000711	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—systemic scleroderma	0.000144	0.000711	CcSEcCtD
Naratriptan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000709	CcSEcCtD
Naratriptan—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000707	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—systemic scleroderma	0.000143	0.000706	CcSEcCtD
Naratriptan—Rash—Azathioprine—systemic scleroderma	0.000143	0.000705	CcSEcCtD
Naratriptan—Dermatitis—Azathioprine—systemic scleroderma	0.000143	0.000705	CcSEcCtD
Naratriptan—Depression—Methotrexate—systemic scleroderma	0.000143	0.000704	CcSEcCtD
Naratriptan—Headache—Azathioprine—systemic scleroderma	0.000142	0.000701	CcSEcCtD
Naratriptan—Dizziness—Leflunomide—systemic scleroderma	0.000142	0.000699	CcSEcCtD
Naratriptan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00014	0.00069	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—systemic scleroderma	0.00014	0.000688	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000687	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—systemic scleroderma	0.000139	0.000685	CcSEcCtD
Naratriptan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00068	CcSEcCtD
Naratriptan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00068	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—systemic scleroderma	0.000137	0.000678	CcSEcCtD
Naratriptan—Sweating—Methotrexate—systemic scleroderma	0.000137	0.000677	CcSEcCtD
Naratriptan—Vomiting—Leflunomide—systemic scleroderma	0.000136	0.000672	CcSEcCtD
Naratriptan—Alopecia—Prednisone—systemic scleroderma	0.000136	0.000671	CcSEcCtD
Naratriptan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000136	0.000669	CcSEcCtD
Naratriptan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000135	0.000666	CcSEcCtD
Naratriptan—Rash—Leflunomide—systemic scleroderma	0.000135	0.000666	CcSEcCtD
Naratriptan—Dermatitis—Leflunomide—systemic scleroderma	0.000135	0.000665	CcSEcCtD
Naratriptan—Nausea—Azathioprine—systemic scleroderma	0.000135	0.000664	CcSEcCtD
Naratriptan—Headache—Leflunomide—systemic scleroderma	0.000134	0.000662	CcSEcCtD
Naratriptan—Erythema—Prednisone—systemic scleroderma	0.000134	0.000661	CcSEcCtD
Naratriptan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000655	CcSEcCtD
Naratriptan—Asthenia—Lisinopril—systemic scleroderma	0.000132	0.000651	CcSEcCtD
Naratriptan—Pruritus—Lisinopril—systemic scleroderma	0.00013	0.000642	CcSEcCtD
Naratriptan—Vomiting—Mycophenolic acid—systemic scleroderma	0.00013	0.000641	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—systemic scleroderma	0.000129	0.000637	CcSEcCtD
Naratriptan—Rash—Mycophenolic acid—systemic scleroderma	0.000129	0.000635	CcSEcCtD
Naratriptan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000129	0.000635	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—systemic scleroderma	0.000129	0.000634	CcSEcCtD
Naratriptan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000632	CcSEcCtD
Naratriptan—Headache—Mycophenolic acid—systemic scleroderma	0.000128	0.000631	CcSEcCtD
Naratriptan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000629	CcSEcCtD
Naratriptan—Nausea—Leflunomide—systemic scleroderma	0.000127	0.000627	CcSEcCtD
Naratriptan—Vision blurred—Prednisone—systemic scleroderma	0.000126	0.000623	CcSEcCtD
Naratriptan—Diarrhoea—Lisinopril—systemic scleroderma	0.000126	0.000621	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisone—systemic scleroderma	0.000124	0.000613	CcSEcCtD
Naratriptan—Anaemia—Prednisone—systemic scleroderma	0.000124	0.000611	CcSEcCtD
Naratriptan—Agitation—Prednisone—systemic scleroderma	0.000123	0.000607	CcSEcCtD
Naratriptan—Dizziness—Lisinopril—systemic scleroderma	0.000122	0.0006	CcSEcCtD
Naratriptan—Nausea—Mycophenolic acid—systemic scleroderma	0.000121	0.000599	CcSEcCtD
Naratriptan—Malaise—Prednisone—systemic scleroderma	0.000121	0.000596	CcSEcCtD
Naratriptan—Vertigo—Prednisone—systemic scleroderma	0.00012	0.000593	CcSEcCtD
Naratriptan—Syncope—Prednisone—systemic scleroderma	0.00012	0.000592	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—systemic scleroderma	0.00012	0.000591	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—systemic scleroderma	0.000119	0.000589	CcSEcCtD
Naratriptan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000586	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—systemic scleroderma	0.000118	0.000581	CcSEcCtD
Naratriptan—Vomiting—Lisinopril—systemic scleroderma	0.000117	0.000577	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—systemic scleroderma	0.000117	0.000575	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—systemic scleroderma	0.000116	0.000573	CcSEcCtD
Naratriptan—Rash—Lisinopril—systemic scleroderma	0.000116	0.000572	CcSEcCtD
Naratriptan—Convulsion—Prednisone—systemic scleroderma	0.000116	0.000572	CcSEcCtD
Naratriptan—Dermatitis—Lisinopril—systemic scleroderma	0.000116	0.000572	CcSEcCtD
Naratriptan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000571	CcSEcCtD
Naratriptan—Chills—Methotrexate—systemic scleroderma	0.000115	0.000569	CcSEcCtD
Naratriptan—Headache—Lisinopril—systemic scleroderma	0.000115	0.000569	CcSEcCtD
Naratriptan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000563	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—systemic scleroderma	0.000114	0.000562	CcSEcCtD
Naratriptan—Myalgia—Prednisone—systemic scleroderma	0.000114	0.000562	CcSEcCtD
Naratriptan—Anxiety—Prednisone—systemic scleroderma	0.000114	0.00056	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—systemic scleroderma	0.000114	0.00056	CcSEcCtD
Naratriptan—Discomfort—Prednisone—systemic scleroderma	0.000113	0.000556	CcSEcCtD
Naratriptan—Erythema—Methotrexate—systemic scleroderma	0.000112	0.000552	CcSEcCtD
Naratriptan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000544	CcSEcCtD
Naratriptan—Nausea—Lisinopril—systemic scleroderma	0.000109	0.000539	CcSEcCtD
Naratriptan—Oedema—Prednisone—systemic scleroderma	0.000109	0.000539	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000109	0.000539	CcSEcCtD
Naratriptan—Infection—Prednisone—systemic scleroderma	0.000109	0.000536	CcSEcCtD
Naratriptan—Shock—Prednisone—systemic scleroderma	0.000108	0.00053	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—systemic scleroderma	0.000107	0.000529	CcSEcCtD
Naratriptan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000526	CcSEcCtD
Naratriptan—Skin disorder—Prednisone—systemic scleroderma	0.000106	0.000524	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisone—systemic scleroderma	0.000106	0.000521	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—systemic scleroderma	0.000106	0.00052	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000104	0.000512	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—systemic scleroderma	0.000103	0.00051	CcSEcCtD
Naratriptan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000506	CcSEcCtD
Naratriptan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000501	CcSEcCtD
Naratriptan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000501	CcSEcCtD
Naratriptan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000498	CcSEcCtD
Naratriptan—Malaise—Methotrexate—systemic scleroderma	0.000101	0.000498	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—systemic scleroderma	0.000101	0.000496	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.96e-05	0.000491	CcSEcCtD
Naratriptan—Paraesthesia—Prednisone—systemic scleroderma	9.82e-05	0.000484	CcSEcCtD
Naratriptan—Cough—Methotrexate—systemic scleroderma	9.77e-05	0.000482	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—systemic scleroderma	9.7e-05	0.000478	CcSEcCtD
Naratriptan—Nausea—Mycophenolate mofetil—systemic scleroderma	9.58e-05	0.000472	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—systemic scleroderma	9.53e-05	0.00047	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—systemic scleroderma	9.53e-05	0.00047	CcSEcCtD
Naratriptan—Fatigue—Prednisone—systemic scleroderma	9.43e-05	0.000465	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—systemic scleroderma	9.42e-05	0.000464	CcSEcCtD
Naratriptan—Constipation—Prednisone—systemic scleroderma	9.35e-05	0.000461	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—systemic scleroderma	9.21e-05	0.000454	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—systemic scleroderma	9.14e-05	0.000451	CcSEcCtD
Naratriptan—Infection—Methotrexate—systemic scleroderma	9.08e-05	0.000448	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisone—systemic scleroderma	9.01e-05	0.000444	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—systemic scleroderma	8.96e-05	0.000442	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—systemic scleroderma	8.95e-05	0.000441	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—systemic scleroderma	8.87e-05	0.000438	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—systemic scleroderma	8.83e-05	0.000436	CcSEcCtD
Naratriptan—Urticaria—Prednisone—systemic scleroderma	8.69e-05	0.000428	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—systemic scleroderma	8.64e-05	0.000426	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—systemic scleroderma	8.54e-05	0.000421	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.32e-05	0.00041	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—systemic scleroderma	8.2e-05	0.000405	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—systemic scleroderma	8.15e-05	0.000402	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—systemic scleroderma	8.12e-05	0.000401	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisone—systemic scleroderma	8.05e-05	0.000397	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.89e-05	0.000389	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—systemic scleroderma	7.88e-05	0.000388	CcSEcCtD
Naratriptan—Asthenia—Prednisone—systemic scleroderma	7.84e-05	0.000387	CcSEcCtD
Naratriptan—Pain—Methotrexate—systemic scleroderma	7.81e-05	0.000385	CcSEcCtD
Naratriptan—Pruritus—Prednisone—systemic scleroderma	7.73e-05	0.000381	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—systemic scleroderma	7.53e-05	0.000371	CcSEcCtD
Naratriptan—Diarrhoea—Prednisone—systemic scleroderma	7.48e-05	0.000369	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—systemic scleroderma	7.26e-05	0.000358	CcSEcCtD
Naratriptan—Dizziness—Prednisone—systemic scleroderma	7.23e-05	0.000356	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—systemic scleroderma	7.22e-05	0.000356	CcSEcCtD
Naratriptan—Vomiting—Prednisone—systemic scleroderma	6.95e-05	0.000343	CcSEcCtD
Naratriptan—Rash—Prednisone—systemic scleroderma	6.89e-05	0.00034	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—systemic scleroderma	6.89e-05	0.00034	CcSEcCtD
Naratriptan—Headache—Prednisone—systemic scleroderma	6.85e-05	0.000338	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—systemic scleroderma	6.73e-05	0.000332	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—systemic scleroderma	6.56e-05	0.000323	CcSEcCtD
Naratriptan—Nausea—Prednisone—systemic scleroderma	6.49e-05	0.00032	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—systemic scleroderma	6.46e-05	0.000319	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—systemic scleroderma	6.25e-05	0.000308	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—systemic scleroderma	6.04e-05	0.000298	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—systemic scleroderma	5.81e-05	0.000286	CcSEcCtD
Naratriptan—Rash—Methotrexate—systemic scleroderma	5.76e-05	0.000284	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—systemic scleroderma	5.76e-05	0.000284	CcSEcCtD
Naratriptan—Headache—Methotrexate—systemic scleroderma	5.72e-05	0.000282	CcSEcCtD
Naratriptan—Nausea—Methotrexate—systemic scleroderma	5.43e-05	0.000268	CcSEcCtD
